Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modified binary hammerhead ribozymes with high catalytic activity.

M Vorobjeva1, E Gusseva, M Repkova

  • 1Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia.

Nucleosides, Nucleotides & Nucleic Acids
|October 27, 2005
PubMed
Summary

Modified binary ribozymes show enhanced nuclease resistance and higher catalytic activity for cleaving MDR1 mRNA. These improvements were achieved using Z-modified nucleotides and a thymidine cap.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lytic bacteriophage PM16 specific for Proteus mirabilis: a novel member of the genus Phikmvvirus.

Archives of virology·2016
Same author

Structure-activity relationships in new polycationic molecules based on two 1,4-diazabicyclo[2.2.2]octanes as artificial ribonucleases.

Bioorganic chemistry·2014
Same author

Mechanism of antisense oligonucleotide interaction with natural RNAs.

Journal of biomolecular structure & dynamics·2011
Same author

When the official drug policy failed: self-organization of the people to defend public health interest.

European journal of public health·2011
Same author

[Imaging diagnosis of hermaphroditism in a 3-month-old child].

Journal de radiologie·2007
Same author

Binary hammerhead ribozymes with improved catalytic activity.

Oligonucleotides·2006

Area of Science:

  • Biochemistry
  • Molecular Biology
  • RNA Therapeutics

Background:

  • Hammerhead ribozymes are catalytic RNA molecules with therapeutic potential.
  • Improving ribozyme stability against nucleases is crucial for in vivo applications.
  • MDR1 mRNA is a target for overcoming multidrug resistance in cancer.

Purpose of the Study:

  • To design and evaluate binary hammerhead ribozymes with enhanced nuclease resistance and catalytic activity.
  • To investigate the impact of Z-modified nucleotides and a 3'-3-linked thymidine cap on ribozyme performance.
  • To assess the cleavage efficiency of modified ribozymes against a specific MDR1 mRNA fragment.

Main Methods:

  • Design and synthesis of binary hammerhead ribozymes incorporating Z-modified nucleotides.

Related Experiment Videos

  • Chemical modification of ribozymes with a 3'-3-linked thymidine cap.
  • In vitro cleavage assays using a 190-nucleotide MDR1 mRNA fragment.
  • Comparison of catalytic activity and nuclease resistance with unmodified analogs.

    • Main Results:

    • Incorporation of Z-modified nucleotides and a thymidine cap significantly enhanced nuclease resistance.
    • Modified binary ribozymes demonstrated efficient cleavage of the target MDR1 mRNA fragment.
    • Catalytic activity of the modified ribozymes was substantially higher than their full-length counterparts.

    Conclusions:

    • Z-modified binary hammerhead ribozymes with a thymidine cap represent a promising strategy for improved RNA-based therapeutics.
    • These modifications overcome key limitations of ribozymes, enhancing their stability and catalytic efficiency.
    • The developed ribozymes show potential for targeting MDR1 mRNA in therapeutic contexts.